NCT03195465 is a NA clinical trial of Dark Chocolate in Autism Spectrum Disorder, sponsored by Loma Linda University.

Who is sponsoring NCT03195465?

NCT03195465 is sponsored by Loma Linda University.

What drugs are being tested in NCT03195465?

Interventions in NCT03195465: Dark Chocolate.

What condition does NCT03195465 study?

NCT03195465 studies Autism Spectrum Disorder.

Is NCT03195465 still recruiting?

NCT03195465 is currently terminated. Last updated 2 June 2021.

Are results published for NCT03195465?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-06-02 · How we verify

NCT03195465

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder

Terminated NA Results posted Last updated 2 June 2021

What this trial tests

NA trial testing Dark Chocolate in Autism Spectrum Disorder in 16 participants. Terminated before completion.

Timeline

14 November 2017

Primary endpoint
1 April 2018

1 April 2018

Quick facts

Lead sponsor	Loma Linda University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	16
Start date	14 November 2017
Primary completion	1 April 2018
Estimated completion	1 April 2018
Sites	1 location across United States

Drugs / interventions tested

Dark Chocolate — full drug profile →

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

Loma Linda University

Who can join

Adults 4 to 18, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if routine consumption of high antioxidant cacao can have an effect on the behaviors of children with Autism Spectrum Disorder. This is proposed as children with Autism Spectrum Disorder have elevated oxidative stress markers, such as, free radicals making them highly vulnerable to oxidative damage. Thus, it is proposed that foods high in antioxidant activity can offer protection against oxidative stress and thus impact behaviors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dark Chocolate

Trials testing the same drug.

NCT07418151 — Effect of Maternal Chocolate Consumption on Fetal Non-Stress Test (NST) Reactivity. · NA · recruiting
NCT05290012 — The Effect of Dark Chocolate Consumption on Blood Parameters in Healthy Adult Individuals · NA · completed
NCT04600258 — Chocolate for Patients With Chronic Kidney Disease · NA · completed
NCT03850405 — Dark Chocolate, Cholesterol and Microbiota · NA · unknown
NCT02764203 — ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial · NA · completed

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other Loma Linda University trials

Trials by the same sponsor.

NCT07213843 — Combined Circulatory and Dietary Interventions for Neuropathy · NA · not yet recruiting
NCT07130812 — Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain. · NA · recruiting
NCT06673342 — Effectiveness of a Nutritional Counseling Tool in Reducing the Amount and Frequency of Sugar Intake · NA · completed
NCT06445842 — Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women · NA · recruiting
NCT07396831 — Necessity of Post-operative Eye Drops · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03195465 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loma Linda University
Last refreshed: 2 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03195465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing